You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-AKT1 Substrate 1 (Proline-Rich) (AKT1S1) Antibodies

Full name:
anti-AKT1 Substrate 1 (Proline-Rich) Antibodies (AKT1S1)
On are 89 AKT1 Substrate 1 (Proline-Rich) (AKT1S1) Antibodies from 16 different suppliers available. Additionally we are shipping AKT1 Substrate 1 (Proline-Rich) Kits (9) and AKT1 Substrate 1 (Proline-Rich) Proteins (5) and many more products for this protein. A total of 112 AKT1 Substrate 1 (Proline-Rich) products are currently listed.
1110012J22Rik, AI227026, fb34a04, Lobe, Lobel, MGC81452, PRAS40, wu:fb34a04
list all antibodies Gene Name GeneID UniProt
AKT1S1 84335 Q96B36
AKT1S1 67605 Q9D1F4
AKT1S1 292887  

Show all species

Show all synonyms

Most Popular Reactivities for anti-AKT1 Substrate 1 (Proline-Rich) (AKT1S1) Antibodies

Select your species and application

anti-Human Antibodies:

anti-Mouse (Murine) Antibodies:

anti-Rat (Rattus) Antibodies:

All available anti-AKT1 Substrate 1 (Proline-Rich) Antibodies

Go to our pre-filtered search.

Top referenced anti-AKT1 Substrate 1 (Proline-Rich) Antibodies

  1. Human Polyclonal AKT1S1 Primary Antibody for IHC (p), WB - ABIN658196 : Wang, Harris, Lawrence: Regulation of proline-rich Akt substrate of 40 kDa (PRAS40) function by mammalian target of rapamycin complex 1 (mTORC1)-mediated phosphorylation. in The Journal of biological chemistry 2008 (PubMed)
    Show all 3 references for ABIN658196

  2. Cow (Bovine) Polyclonal AKT1S1 Primary Antibody for WB - ABIN2783209 : Fonseca, Lee, Proud: The binding of PRAS40 to 14-3-3 proteins is not required for activation of mTORC1 signalling by phorbol esters/ERK. in The Biochemical journal 2008 (PubMed)

More Antibodies against AKT1 Substrate 1 (Proline-Rich) Interaction Partners

Human AKT1 Substrate 1 (Proline-Rich) (AKT1S1) interaction partners

  1. PRAS40 was downregulated in the DU145 cells following MYO6 (show MYO6 Antibodies) knockdown.

  2. Phosphorylation of S202/203 of AKT1S1 by PKM2 released AKT1S1 from raptor (show RPTOR Antibodies) and facilitated its binding to 14-3-3 (show YWHAQ Antibodies), resulted in hormonal- and nutrient-signals independent activation of mTORC1 signaling and led accelerated oncogenic growth and autophagy inhibition in cancer cells.

  3. The frameshift mutation detected in the current study would result in a premature stop of amino-acid synthesis in AKT1S1 protein and hence resembles a typical loss-of-function mutation.

  4. Supporting this idea, we identified a downstream target of the TGFb (show TGFB1 Antibodies)-miR (show MLXIP Antibodies)-96 signaling pathway to be AKT1S1 mRNA, whose translated protein is a negative regulator of mTOR (show FRAP1 Antibodies) kinase.

  5. This review discusses the role of PRAS40 and possible feedback mechanisms, and alterations in AKT (show AKT1 Antibodies)/PRAS40/mTOR (show FRAP1 Antibodies) signaling that have been implicated in the pathogenesis of tumor progression. [review]

  6. Findings indicate that dual phosphorylation of PRAS40 by Akt (show AKT1 Antibodies) and mTORC1 promotes formation of a nuclear-specific PRAS40- and RPL11 (show RPL11 Antibodies)-containing complex distinct from mTORC1 that inhibits the RPL11 (show RPL11 Antibodies)-HDM2-p53 (show TP53 Antibodies) pathway.

  7. PRAS40 as a regulator of insulin (show INS Antibodies) sensitivity in hSkMC

  8. PRAS40 contains a functional nuclear export signal. Furthermore, enforced nuclear accumulation of PRAS40 impairs insulin (show INS Antibodies) action, thereby substantiating the function of this protein in the regulation of insulin (show INS Antibodies) sensitivity.

  9. Data suggest that PRAS40 modulates insulin (show INS Antibodies) action in skeletal muscle; knockdown of PRAS40 inhibits insulin (show INS Antibodies) action in cultured myotubes and is associated with up-regulation of IRS1 (insulin receptor substrate 1 (show IRS1 Antibodies)) degradation via proteasome proteolysis.

  10. WISP1 (show WISP1 Antibodies) governs PRAS40 by sequestering PRAS40 intracellularly through post-translational phosphorylation.

Mouse (Murine) AKT1 Substrate 1 (Proline-Rich) (AKT1S1) interaction partners

  1. PRAS40 appears to reduce brain injury following ischemic stroke by converting cell signaling from Akt (show AKT1 Antibodies) to mTOR (show FRAP1 Antibodies)

  2. PRAS40 treatment improves hepatic insulin (show INS Antibodies) sensitivity and reduces systemic hyperglycaemia in obese mice.

  3. PRAS40 phosphorylation acts as a molecular switch allowing mTORC1 activation during physiological growth, opening up unique possibilities for therapeutic regulation of the mTORC1 complex to mitigate pathologic myocardial hypertrophy by PRAS40

  4. Naturally secreted amyloid-beta increases mammalian target of rapamycin (mTOR (show FRAP1 Antibodies)) activity via a PRAS40-mediated mechanism.

  5. These results suggest that a reduction in PRAS40 specifically impairs myoblast protein synthesis, cell cycle, proliferation and differentiation to myotubes.

  6. PRAS phosphorylation and its interaction with pAkt and 14-3-3 might play an important role in neuroprotection mediated by NGF in apoptotic neuronal cell death after transient focal cerebral ischemia

  7. overexpression of SOD1 (show SOD1 Antibodies) may affect the PRAS pathway after transient focal cerebral ischemia by reducing the direct oxidative reaction to pPRAS after reperfusion injury

  8. PRAS40 is an important regulator of insulin (show INS Antibodies) sensitivity of the Akt (show AKT1 Antibodies)-mTOR (show FRAP1 Antibodies) pathway and a potential target for the treatment of cancers, insulin (show INS Antibodies) resistance and hamartoma syndromes.

  9. PRAS40 regulates mTORC1 kinase activity by functioning as a direct inhibitor of substrate binding.

  10. after mTORC1 kinase activation by upstream regulators, PRAS40 is phosphorylated directly by mTOR (show FRAP1 Antibodies), thus contributing to the relief of PRAS40-mediated substrate competition.

AKT1 Substrate 1 (Proline-Rich) (AKT1S1) Antigen Profile

Antigen Summary

AKT1S1 is a proline-rich substrate of AKT (MIM 164730) that binds 14-3-3 protein (see YWHAH, MIM 113508) when phosphorylated (Kovacina et al., 2003

Alternative names and synonyms associated with AKT1 Substrate 1 (Proline-Rich) (AKT1S1)

  • AKT1 substrate 1 (proline-rich) (akt1s1) antibody
  • AKT1 substrate 1 (proline-rich) (AKT1S1) antibody
  • AKT1 substrate 1 (proline-rich) (Akt1s1) antibody
  • 1110012J22Rik antibody
  • AI227026 antibody
  • fb34a04 antibody
  • Lobe antibody
  • Lobel antibody
  • MGC81452 antibody
  • PRAS40 antibody
  • wu:fb34a04 antibody

Protein level used designations for AKT1S1

AKT1 substrate 1 (proline-rich) , proline-rich AKT1 substrate 1 , 40 kDa proline-rich AKT substrate , proline-rich AKT substrate , PKB/Akt substrate 40

431814 Xenopus laevis
456218 Pan troglodytes
496515 Xenopus (Silurana) tropicalis
566559 Danio rerio
84335 Homo sapiens
67605 Mus musculus
292887 Rattus norvegicus
610130 Canis lupus familiaris
514859 Bos taurus
Selected quality suppliers for anti-AKT1 Substrate 1 (Proline-Rich) (AKT1S1) Antibodies
Did you look for something else?